Impact of Precursor Thermal Decomposition Reactions on YSZ Coatings Deposited with a Low-Power Plasma Torch at Short Spray DistanceJOURNAL OF THERMAL SPRAY TECHNOLOGYIF3.32022-12-160PRE
Low power plasma spray assisted thermal barrier coating repair without the plugging of cooling holesSURFACE & COATINGS TECHNOLOGYIF6.12021-04-013OAAI
Pharmacokinetics and Bioavailability of Monomethyl Fumarate Following a Single Oral Dose of Bafiertam™ (Monomethyl Fumarate) or Tecfidera(R) (Dimethyl Fumarate)CNS DRUGSIF7.42021-03-3020OAAI
DINAS: A Lightweight and Efficient Distributed Naming Service for All-IP Wireless Sensor NetworksIEEE INTERNET OF THINGS JOURNALIF8.92017-06-0110PREAI
GreenNet: An Energy-Harvesting IP-Enabled Wireless Sensor NetworkIEEE INTERNET OF THINGS JOURNALIF8.92015-10-0134PREAI
Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapyHEPATOLOGY INTERNATIONALIF6.12015-03-1217PREAI
Phase 2b, randomized, double-blind 12-week studies of TZP-102, a ghrelin receptor agonist for diabetic gastroparesisNEUROGASTROENTEROLOGY AND MOTILITYIF2.92013-07-1568PREAI
Safety and Efficacy of Ulimorelin Administered Postoperatively to Accelerate Recovery of Gastrointestinal Motility Following Partial Bowel Resection: Results of Two Randomized, Placebo-Controlled Phase 3 TrialsDISEASES OF THE COLON & RECTUMIF3.72013-07-0142PREAI
A phase 2a, randomized, double-blind 28-day study of TZP-102 a ghrelin receptor agonist for diabetic gastroparesisNEUROGASTROENTEROLOGY AND MOTILITYIF2.92012-12-2367PREAI
A phase 2, randomized, double-blind, placebo-controlled study of GS-9450 in subjects with nonalcoholic steatohepatitisHEPATOLOGYIF15.82012-02-01139OAAI
Three-Year Efficacy and Safety of Tenofovir Disoproxil Fumarate Treatment for Chronic Hepatitis BGASTROENTEROLOGYIF25.12011-01-01420OA
Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver DiseaseHEPATOLOGYIF15.82011-01-01269PREAI
Tenofovir Is Effective Alone or With Emtricitabine in Adefovir-Treated Patients With Chronic-Hepatitis B Virus InfectionGASTROENTEROLOGYIF25.12010-10-01122OA
SHORT TERM SAFETY, TOLERABILITY, PHARMACOKINETICS AND PRELIMINARY ACTIVITY OF GS-9450, A SELECTIVE CASPASE INHIBITOR, IN PATIENTS WITH CHRONIC HCV INFECTIONJOURNAL OF HEPATOLOGYIF332010-04-013OAAI
HBSAG KINETICS OF DECAY AND BASELINE CHARACTERISTICS OF HBEAG-POSITIVE PATIENTS WITH CHRONIC HEPATITIS B FOLLOWING 3 YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENTJOURNAL OF HEPATOLOGYIF332010-04-0113OAAI
EMTRICITABINE TENOFOVIR DF COMBINATION plus /- HBIG POST-ORTHOTOPIC LIVER TRANSPLANTATION TO PREVENT HEPATITIS B RECURRENCE IN PATIENTS WITH NORMAL TO MODERATE RENAL IMPAIRMENT: INTERIM RESULTSJOURNAL OF HEPATOLOGYIF332010-04-0115OAAI
SAFETY, TOLERABILITY AND PRELIMINARY ACTIVITY OF GS-9450, A SELECTIVE CASPASE INHIBITOR, IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH)JOURNAL OF HEPATOLOGYIF332010-04-015PREAI
DOSE-RANGING, THREE-DAY MONOTHERAPY STUDY OF THE HCV NS3 PROTEASE INHIBITOR GS-9256JOURNAL OF HEPATOLOGYIF332010-04-0113PREAI
THREE YEARS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBEAG-NEGATIVE AND POSITIVE PATIENTS WITH CHRONIC HEPATITIS B (STUDY 102 AND STUDY 103)DIGESTIVE AND LIVER DISEASEIF3.82010-02-010PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向